Reference
Reiter FP, et al. Profound tumor response to combined CTLA-4 and PD-1 inhibition in systemic fourth line therapy observed in a patient with hepatocellular carcinoma harboring SETD2 and LRP1B mutations. Zeitschrift fur Gastroenterologie 61: 71-75, No. 1, Jan 2023. Available from: URL: http://doi.org/10.1055/a-1952-1233
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1951, 46 (2023). https://doi.org/10.1007/s40278-023-36823-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-36823-3